title: Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats.
abstract: Quantification of visual function is essential for the impact of disease models and their treatment. Recently, we introduced a chronic implant model to record visual evoked potentials (VEP) in awake Brown-Norway rats. Here, we investigated the hemispheric distribution of VEP after monocular stimulation, the chronic electrode implantation and the influence of commonly used anesthetics. Potentials were recorded by electrodes, implanted epidurally over the superior colliculus. The entire visual field of the rat was stimulated. Flicker stimuli were modulated in luminance with a modulation depth from 5 to 80% at 7.5 Hz and flashes with a modulation depth of >95% in a frequency range of 2.9-38 Hz. Recordings were constant over 9 days. When one eye was blinded, the potentials recorded from the contralateral side were not affected, while the potentials of the ipsilateral side were markedly reduced. Further, potentials of awake animals were compared with those receiving general anesthetics. For one group of rats (n = 8), we administered isoflurane by inhalation in five concentrations. Four different groups (n = 7-11) were given choralhydrate (200 and 400 mg/kg) and the combination of ketamine/xyaline (65/7 or 130/14 mg/kg, respectively) intraperitoneally. Isoflurane depressed the VEP in a concentration-dependent manner. Treatment with chloralhydrate and ketamine/xyaline increased the VEP at low concentrations and depressed it in high concentrations. The new VEP paradigm assesses distinct qualities of contrast vision in rats. All tested narcotics alter VEP amplitudes and can be avoided.
authors.affiliation: Universtity Eye Hospital Freiburg, Killianstrasse 5, 79106, Freiburg im Breisgau, Germany. thomas.jehle@uniklinik-freiburg.de
authors.forename: T
authors.initials: T
authors.lastname: Jehle
authors.forename: D
authors.initials: D
authors.lastname: Ehlken
authors.forename: K
authors.initials: K
authors.lastname: Wingert
authors.forename: T J
authors.initials: TJ
authors.lastname: Feuerstein
authors.forename: M
authors.initials: M
authors.lastname: Bach
authors.forename: W A
authors.initials: WA
authors.lastname: Lagrèze
mesh_terms: D000280:Administration, Inhalation; D000778:Anesthetics, Dissociative / Q000494:pharmacology; D018685:Anesthetics, Inhalation / Q000494:pharmacology; D000818:Animals; D002697:Chloral Hydrate / Q000494:pharmacology; D015350:Contrast Sensitivity / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004567:Electrodes, Implanted; D005074:Evoked Potentials, Visual / Q000187:drug effects*; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007530:Isoflurane / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology; D008029:Lighting; D008297:Male; D009294:Narcotics / Q000008:administration & dosage / Q000494:pharmacology*; D010775:Photic Stimulation / Q000379:methods*; D051381:Rats; D011914:Rats, Inbred BN; D013997:Time Factors; D015349:Vision, Monocular / Q000502:physiology*
chemical_list: D000778:Anesthetics, Dissociative; D018685:Anesthetics, Inhalation; D006993:Hypnotics and Sedatives; D009294:Narcotics; D002697:Chloral Hydrate; D007649:Ketamine; D007530:Isoflurane